Raymond James RJF is scheduled to announce second-quarter fiscal 2025 (ended March 31) results on April 23, after market close. The company’s earnings and revenues are expected to have witnessed a rise on a year-over-year basis. In the last quarter, RJF’s earnings beat the Zacks Consensus Estimate. Results benefited from robust investment banking (IB) and brokerage performance in the Capital Markets segment. The performance of the Private Client Group and Asset Management segments was also solid. The acquisitions over the past years supported the company’s financials. However, higher non-interest expenses acted as a headwind. Raymond James has an impressive earnings surprise history. Its earnings outpaced the Zacks Consensus Estimate thrice in the trailing four quarters and missed once, with the average beat being 7.75%. Raymond James Financial, Inc. Price and EPS SurpriseRaymond James Financial, Inc. Price and EPS Surprise Raymond James Financial, Inc. price-eps-surprise | Raymond James Financial, Inc. Quote The Zacks Consensus Estimate for the company’s fiscal second-quarter earnings is pegged at $2.44, which has remained unchanged over the past seven days. The figure indicates growth of 5.6% from the year-ago quarter. The consensus estimate for sales of $3.43 billion suggests 9.9% year-over-year growth. Key Performance Drivers for Raymond James’ Q2 Earnings IB Fees: Global mergers and acquisitions (M&As) in the first quarter of 2025 were less impressive than previously expected. Deal value and volume rose marginally during the quarter, mainly led by the Asia Pacific region. Ambiguity over the tariff policies and ensuing trade war resulted in extreme market volatility. These led to economic uncertainty, with data indicating a slowdown in the U.S. economy and rising inflationary pressure. Hence, amid such a backdrop, companies started rethinking their M&A plans despite stabilizing rates and having significant investible capital. Also, the IPO market saw signs of cautious optimism, given the market volatility, geopolitical challenges and rising flotation costs. The equity market performance drove some decent activity in follow-up equity issuances. Nonetheless, bond issuance volume was strong on solid investor demand and tighter spreads, but uncertainties continue to persist due to a tough macroeconomic environment. Thus, RJF’s underwriting fees are expected to have been positively impacted in the quarter. The consensus estimate for IB fees is pegged at $255.8 million, suggesting a 42.9% jump on a year-over-year basis. We anticipate IB fees to be $253.1 million. Trading Revenues: Client activity and market volatility were robust in the March-ended quarter. The likelihood of a trade war, sticky inflation and higher-for-longer interest rates alongside recessionary fears drove client activity. Further, volatility was high in equity markets and other asset classes, including commodities, bonds, and foreign exchange. So, Raymond James’ trading revenues are likely to have witnessed solid growth. Net Interest Income (NII): The Federal Reserve kept interest rates unchanged at 4.25%-4.5% during the quarter due to persisting inflation and uncertainties regarding the impact of tariff policies. This is likely to have had a favorable impact on RJF’s NII to some extent, with higher yields being partially offset by higher funding costs. Further, the yield curve steepened during the quarter, which is likely to have supported NII on the back of improved yields on loans and securities. Lending activities improved in the to-be-reported quarter as per the Fed’s latest data. The Zacks Consensus Estimate for interest income stands at $993.1 million, indicating a decline of 5.3%. Our estimate for the metric is $1.01 billion. Management anticipates aggregate NII and Raymond James Bank Deposit Program (RJBDP) third-party fees to be down 2-3% sequentially due to two fewer billing days in the second quarter of fiscal 2025. Expenses: Raymond James consistently hires advisors and invests in franchises. Thus, overall expenses are expected to have increased in the to-be-reported quarter. Due to a highly competitive environment and inflationary pressure, expenses are likely to have risen. We project total non-interest expenses to be $2.75 billion, implying a 9.6% year-over-year increase. Story Continues RJF’s Outlook for Q2 Management expects asset management and related administrative fees to decline nearly 2% from the prior quarter. What the Zacks Model Unveils for Raymond James According to our proven model, the chances of Raymond James beating the Zacks Consensus Estimate this time are low. This is because it lacks the right combination of two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Earnings ESP: The Earnings ESP for Raymond James is 0.00%. Zacks Rank: The company currently has a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Finance Stocks Worth a Look Here are a couple of finance stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time: The Earnings ESP for Synchrony Financial SYF is +1.29%, and it carries a Zacks Rank #3 at present. The company is slated to report first-quarter 2025 results on April 22. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Over the past seven days, the Zacks Consensus Estimate for SYF’s quarterly earnings has remained unchanged at $1.66 per share. Ameriprise Financial, Inc. AMP is scheduled to release first-quarter 2025 numbers on April 24. The company has an Earnings ESP of +0.04% and carries a Zacks Rank #3 at present. Quarterly earnings estimates for AMP have been revised marginally downward to $9.12 per share over the past week. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ameriprise Financial, Inc. (AMP):Free Stock Analysis Report Raymond James Financial, Inc. (RJF):Free Stock Analysis Report Synchrony Financial (SYF):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
IB & Trading to Aid Raymond James' Q2 Earnings, High Costs to Hurt
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...